120 INTERVENČNÍ A AKUTNÍ KARDIOLOGIE / Interv Akut Kardiol. 2023;22(3):114-120 / www.iakardiologie.cz PŘEHLEDOVÉ ČLÁNKY / REVIEW ARTICLES Valve‑in‑valve transkatétrová implantaceaortální chlopně nosis (PARTNER 1): a randomised controlled trial. Lancet. 2015;385(9986):2485-491. 3. Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic‑valve replacement in high‑risk patients. N Engl J Med. 2011;364(23):2187-2198. 4. Reardon MJ, Adams DH, Kleiman NS, et al. 2-year outcomes in patients undergoing surgical or self‑expanding transcatheter aortic valve replacement. J Am Coll Cardiol. 2015;66(2):113-121. 5. Leon MB, Smith CR, Mack MJ, et al. Transcatheter or Surgical Aortic‑Valve Replacement in Intermediate‑Risk Patients. N Engl J Med. 2016;374(17):1609-1620. 6. Reardon MJ, Van Mieghem NM, Popma JJ, et al. Surgical or transcatheter Aortic‑Valve replacement in intermediate risk – patients. N Engl J Med. 2017;376:1321-1331. 7. Thyregod HG, Steinbrüchel DA, Ihlemann N, et al. Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1-year results from the all ‑comers NOTION randomized clinical trial. J Am Coll Cardiol. 2015;65(20):2184-2194. 8. Popma JJ, Deeb GM, Yakubov SJ. Transcatheter aortic valve replacement with a self‑expanding valve in low‑risk patients. N Engl J Med. 2019;380:1706-1715. 9. Mack JM, Leon MB, Thourani VH et al. Transcatheter Aortic‑Valve Replacement with a Balloon‑Expandable Valve in Low‑Risk Patients. N Engl J Med. 2019;380:1695-1705. doi: 10.1056/NEJMoa1814052. 10. Mylotte D, Lange R, Martucci G, et al. Transcatheter heart valve implantation for failing surgical bioprostheses: technical considerations and evidence for valve‑in‑valve procedures. Heart. 2013 Jul;99(13):960-7. doi: 10.1136/heartjnl-2012-301673. Epub 2013 Feb 13. PMID: 23406687. 11. Simonato M, Dvir D. Transcatheter aortic valve replacement in failed surgical valves. Heart. 2019; 105:s38-43. 12. Ribeiro HB, Rodés‑Cabau J, Blanke P, et al. Incidence, predictors, and clinical outcomes of coronary obstruction following transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: insights from the VIVID registry. Eur Heart J. 2018 Feb 21;39(8):687-695. doi: 10.1093/ eurheartj/ehx455. PMID: 29020413. 13. Dvir D, Leipsic J, Blanke P, et al. Coronary obstruction in transcatheter aortic valve‑in‑valve implantation: preprocedural evaluation, device selection, protection, and treatment. Circ Cardiovasc Interv. 2015 Jan;8(1):e002079. doi: 10.1161/CIRCINTERVENTIONS.114.002079. PMID: 25593122. 14. Awedimento M, Tang GHL. Commissural alignment in TAVI: a new frontier to facilitate coronary reaccess and Redo TAVI. Mini‑invasive Surg. 2022;6:24. 10. 20517/25741225.2021.143. 15. Pibarot P, Simonato M, Barbanti M, et al. Impact of Pre ‑Existing Prosthesis‑Patient Mismatch on Survival Following Aortic Valve‑in‑Valve Procedures. JACC Cardiovasc Interv. 2018 Jan 22;11(2):133-141. doi: 10.1016/j.jcin.2017. 08. 039. PMID: 29348008. 16. Almomani A, Chhatriwalla A. Bioprosthetic Valve Fracture During ViV TAVR: A step‑by‑step practical guide for performing BVF to facilitate ViV TAVR. Cardiac interventions today. 2019;13(2). 17. Blanke P, Leipsig JA, Popma JJ, et al. Evolut Low Risk LTI Substudy Investigators. Bioprosthetic aortic valve leaflet thickening in the Evolut low risk sub‑study. J Am Coll Cardiol. 2020;75:2430-42. 18. Dangas GD, Tijssen JGP, Wohrle J. A Controlled Trial of Rivaroxaban after Transcatheter Aortic‑Valve Replacement. N Engl J Med. 2020; 382:120-129. doi: 10.1056/ NEJMoa1911425. 19. Collet JP, Berti S, Cequier A, et al. Oral anti‑Xa anticoagulation after trans‑aortic valve implantation for aortic stenosis: The randomized ATLANTIS trial. Am Heart J. 2018 Jun;200:44-50. doi:10.1016/j.ahj.2018. 03. 008. Epub 2018 Mar 10. 20. Nijenhuis VJ, Brouwer J, Delewi R, et al. Anticoagulation with or without Clopidogrel after Transcatheter Aortic ‑Valve Implantation. N Engl J Med. 2020;382:1696-1707. doi: 10.1056/NEJMoa1915152. 21. Alperi A, Rodés‑Cabau J, Simonato M, et al. Permanent Pacemaker Implantation Following Valve‑in‑Valve Transcatheter Aortic Valve Replacement: VIVID Registry. J Am Coll Cardiol. 2021 May;77(18):2263-2273. https://doi.org/10.1016/j.jacc.2021. 03. 228. 22. Tarantini G, Fabris T, Nai Fovino L. TAVR‑in‑TAVR and coronary access: importance of preprocedural planning. EuroIntervention. 2020 Jun 12;16(2):e129-e132. doi: 10.4244/EIJ‑D-19-01094. PMID: 32091405. 23. Annibali G, Scrocca I, Musumeci G. Valve‑in‑valve transcatheter aortic valve replacement: the challenge of the next future. Mini‑invasive Surg. 2022;6:12. http://dx.doi.org/10.20517/25741225.2021.101.
RkJQdWJsaXNoZXIy NDA4Mjc=